Technology | Hemostasis Management | February 01, 2019

PreludeSync Distal Compression Device Available Globally

First product known to be specifically designed for use in distal transradial anatomical “snuff box” procedures that assists in achieving patent hemostasis

PreludeSync Distal Compression Device Available Globally

February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available in the United States, European, Middle Eastern, African and Asia-Pacific markets. The device is the first specifically designed to achieve hemostasis of the radial artery during procedures where access is gained via the distal radial artery.

Designed with a comfortable band and a large window for site visibility, the PreludeSync Distal Compression Device is easily applied over the arteriotomy, allowing the clinician to slowly inflate the balloon with air while simultaneously removing the sheath. It then maintains pressure at the site to allow the access wound to achieve patent hemostasis.  

Merit also announced a ThinkRadial distal access training course is scheduled for Feb. 9, 2019. The course will feature a dedicated three-hour session specific to distal radial access, which will be streamed live online and available to interventional cardiologists and radiologists who want to learn the distal technique. Those interested can register here.

The live streaming event will provide an opportunity to get an inside look at Merit’s ThinkRadial program, and features:

  • Ferdinand Kiemeneij, M.D., Ph.D., of The Netherlands, who is widely considered the “father of transradial intervention”;
  • Sandeep Nathan, M.D., an interventional cardiologist at the University of Chicago Medical Center; and
  • Darren Klass, M.D., an interventional radiologist at Vancouver Coastal Health, Canada.

The following lectures will be presented during the live streaming event:

  1. dTRA The Next Generation of Radial Access – Kiemeneij
  2. Distal Ultrasound Techniques – Klass
  3. Technique, Pitfalls & Challenges dTRA & Changing the Room Set Up – Kiemeneij
  4. Distal Catheter Specifics to Hemostasis – Nathan
  5. dTRA Taped Cases – Kiemeneij

Watch the VIDEO: History of Radial Artery Access, an interview with Kiemeneij at TCT 2017.

For more information: www.meritmedical.com

Related Content

FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths
News | Cath Lab | April 09, 2019
A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce...
TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy
Technology | Cath Lab | April 08, 2019
TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its...
Cook Medical Recalls Transseptal Needle Due to Risk of Detached Plastic Fragments
News | Cath Lab | March 20, 2019
March 20, 2019 — Cook Medical is recalling one lot of its...
DABRA Excimer Laser System Demonstrates Success in Treating PAD
News | Cath Lab | February 27, 2019
Ra Medical Systems Inc. announced a 98 percent success rate in the results from a 52-patient study using the company’s...
Edwards Lifesciences Recalls Swan-Ganz hemodynamic catheters.
Feature | Cath Lab | February 06, 2019
Edwards Lifesciences is recalling its 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters manufa
Scientists Discover New Heart Attack Repair Pathway

A macrophage immune cell, with a dead cell (pink) that has been eaten, and a mitochondrion (green) between the dead cell and the nucleus. The study’s findings indicate that what the macrophage eats is taken up by the mitochondrion, which in turn communicates with the nucleus to activate the macrophage to promote tissue repair. Image courtesy of Northwestern Medicine.

News | Cath Lab | January 30, 2019
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing after a heart attack....
Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy
News | Cath Lab | January 16, 2019
Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE...
Overlay Init